6-Chloro-N-((1r,3S)-3-hydroxy-3-methylcyclobutyl)-7-((S)-2-methylazetidin-1-yl)-1,8-naphthyridine-3-carboxamide

ID: ALA5278680

Chembl Id: CHEMBL5278680

Max Phase: Preclinical

Molecular Formula: C18H21ClN4O2

Molecular Weight: 360.85

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H]1CCN1c1nc2ncc(C(=O)N[C@H]3C[C@](C)(O)C3)cc2cc1Cl

Standard InChI:  InChI=1S/C18H21ClN4O2/c1-10-3-4-23(10)16-14(19)6-11-5-12(9-20-15(11)22-16)17(24)21-13-7-18(2,25)8-13/h5-6,9-10,13,25H,3-4,7-8H2,1-2H3,(H,21,24)/t10-,13-,18-/m0/s1

Standard InChI Key:  SMXNSFIYYUBDLJ-IMQJOWEQSA-N

Alternative Forms

  1. Parent:

    ALA5278680

    ---

Associated Targets(Human)

HPGDS Tchem Hematopoietic prostaglandin D synthase (658 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hpgds Hematopoietic prostaglandin D synthase (77 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 360.85Molecular Weight (Monoisotopic): 360.1353AlogP: 2.53#Rotatable Bonds: 3
Polar Surface Area: 78.35Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.93CX Basic pKa: CX LogP: 1.58CX LogD: 1.58
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.88Np Likeness Score: -0.73

References

1. Cadilla R, Deaton DN, Do Y, Elkins PA, Ennulat D, Guss JH, Holt J, Jeune MR, King AG, Klapwijk JC, Kramer HF, Kramer NJ, Laffan SB, Masuria PI, McDougal AV, Mortenson PN, Musetti C, Peckham GE, Pietrak BL, Poole C, Price DJ, Rendina AR, Sati G, Saxty G, Shearer BG, Shewchuk LM, Sneddon HF, Stewart EL, Stuart JD, Thomas DN, Thomson SA, Ward P, Wilson JW, Xu T, Youngman MA..  (2020)  The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure.,  28  (23): [PMID:33059303] [10.1016/j.bmc.2020.115791]

Source